The FDA recently updated its labeling for EVOLENCE® based on new data to include safety and efficacy through 12 months. This exciting news follows a similar extension in June 2008 on Allergan's Juvederm™ , also to 12 months. Bioform's Radiesse® was the first to receive 12 month approval in August 2006. This news adds another product to the longer-lasting, non-permanent filler market.
Read Full Article
